granulocyte

Type: Keyphrase
Name: granulocyte
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

Early Cytokine Release in Response to Live Borrelia burgdorferi Sensu Lato Spirochetes Is Largely Complement Independent

by Kerstin Sandholm, Anna J. Henningsson, Susanne Säve, Sven Bergström, Pia Forsberg, Nina Jonsson, Jan Ernerudh, Kristina N. EkdahlAimHere we investigated the role of complement activation in phagocytosis and the release of cytokines and chemokines in ... [Published Plosone.org - Sep 29 2014]
First reported Sep 27 2014 - Updated Sep 27 2014 - 1 reports

Leukocyte Population Dynamics and Detection of IL-9 as a Major Cytokine at the Mouse Fetal-Maternal Interface

IntroductionUnderstanding the intricate mechanisms regulating mammalian fetal-maternal interactions has remained a challenging goal for biologists for several decades [1] . During pregnancy, the maternal immune system faces the double task of protecting ... [Published Plosone.org - Sep 27 2014]
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

Differences in Cellular Immune Competence Explain Parasitoid Resistance for Two Coleopteran Species

by Lisa Fors, Robert Markus, Ulrich Theopold, Peter A. HambäckThe immune defence of an organism is evolving continuously, causing counteradaptations in interacting species, which in turn affect other ecological and evolutionary processes. Until recently ... [Published Plosone.org - Sep 26 2014]
First reported Sep 24 2014 - Updated Sep 24 2014 - 1 reports

A 3-Year-Old Male With Lymphadenopathy and Fever

Morgan H. McCoy, PhD, MD, Kelly Mast, MD, Ryan F. Relich, PhD, MLS(ASCP)CM, George Girgis, MT(ASCP), Medhi Nassiri, MDDisclosuresLab Med. 2014;45(3):244-247.Abstract and Introduction AbstractA 3-year-old male with oculocutaneous albinism presented with ... [Published General Medicine eJournal - Sep 24 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Penticton family fights to recover cancer drug costs

PENTICTON, BC – Shortly after their son’s first birthday, Aaron and Ana Moen received the devastating news that their boy has cancer.Aeson Moen is now 17-months old and entering his fifth cycle of chemotherapy this week.But the treatment doesn’t end ... [Published Global News Canada - Sep 16 2014]
First reported Sep 11 2014 - Updated Sep 12 2014 - 2 reports

Feds give Cellerant $47.5M for stem cell treatment that preps for nuclear disaster

Stem cell therapy ia one way the government’s preparing for a nation impacted by nuclear disaster.Cellerant Therapeutics has received $47.5 million from the government to develop its treatment for radiation poisoning. If approved, the feds could buy the ... [Published MedCity News - Sep 12 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

FortuneRock (China) Gets Investments Totaling $24 Million [Professional Services Close - Up]

FortuneRock (China) recently reported that it has received investments for its ongoing novel protein drug development and pre- IPO funding totaling $24m (RMB145m).In a release, the Company said that RMB120m is to support the set up of a new spin-off enterprise ... [Published Pharmacy Choice - Sep 10 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 1 reports

Sector Update: Health-Care Shares Mixed Pre-Market

PFE: flatABT: flatMRK: +0.05%AMGN: +0.14%Health-care shares were mixed in pre-market trade Tuesday.In health-care stocks news, Spectrum Pharmaceuticals ( SPPI ) said it will advance its SPI-2012 neutropenia drug candidate into phase 3 trials after achieving ... [Published Nasdaq - Sep 09 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 2 reports

Novel immunotherapy vaccine decreases recurrence in HER2 positive breast cancer patients

A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. This is especially the case for high-risk patients when it is combined with a powerful immunotherapy drug. These ... [Published Bio-Medicine - Sep 05 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

Relationship between Native-State Solubility and Non-Native Aggregation of Recombinant Human Granulocyte Colony Stimulating Factor: Practical Implications for Protein Therapeutic Development

Prescreening methods are needed in the biotechnology industry for rapid selection of protein therapeutic candidates and formulations of low aggregation propensity. In recent reports solubility measurements have shown promise as one such method, although ... [Published Molecular Pharmaceutics - Aug 29 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

Mutation disables innate immune system

A Ludwig Maximilian University of Munich team has shown that defects in the JAGN1 gene inhibit the function of a specific type of white blood cells, and account for a rare congenital immune deficiency that increases vulnerability to life-threatening ... [Published Medical Xpress - Aug 29 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

Please help do i have parathyroidism?

Hey guys! I am a 26 year-old male and I am trying to find out what is going on! This is all new to me because till now I have hardly ever been sick my whole life. I maybe had like 2 colds and that's it.Anyways so my symptoms started about 6-8 months or ... [Published HealthBoards - Aug 20 2014]

Quotes

...immune system to treat cancer," says principal investigator Elizabeth Mittendorf, M D , Ph D , associate professorprofessor of Surgical Oncology. "The ultimate goal is to develop a preventative tool that will minimize the risk of recurrence in women who have already had breast cancer and for whom standard therapies have failed."
The MIT/ICBP siRNA Database http:(//)web.mit.edu/sirna/-- "The MIT [Massachusetts Institute of Technology]/ICBP [Integrative Cancer Biology Program] siRNA Database is a university-wide effort to catalog these experimentally validated reagents and make that information available to other researchers, both within and outside the MIT community. (Massachusetts Institute of Technology)."
In addition to obtaining background information on this patent, NewsRx editors also obtained the inventor's summary information for this patent: "Contrary to the inhibition of the catalase, the present invention is based on experimental results, which have shown that the tumor cell catalase can also be inactivated in order to induce selective apoptosis to tumor cells. Although the catalase of the tumor cells is able to inactivate peroxynitrite, it was found in the present experimental studies that this catalase itself can be inactivated if the peroxynitrite level is significantly increased. This will be explained in the following."

More Content

All (77) | News (68) | Reports (0) | Blogs (6) | Audio/Video (0) | Fact Sheets (2) | Press Releases (1)
sort by: Date | Relevance
Early Cytokine Release in Response to Live Borr... [Published Plosone.org - Sep 29 2014]
Leukocyte Population Dynamics and Detection of ... [Published Plosone.org - Sep 27 2014]
Endoglin (CD105) expression differentiates betw... [Published 7thSpace - Sep 27 2014]
Differences in Cellular Immune Competence Expla... [Published Plosone.org - Sep 26 2014]
Blood CellsThe michael kors purses cheap white7... [Published Student Village - Sep 25 2014]
Broad Spectrum Activity of a Lectin-Like Bacter... [Published Plosone.org - Sep 24 2014]
Acupuncture helps cancer sufferers [Published CDA Press - Sep 24 2014]
A 3-Year-Old Male With Lymphadenopathy and Fever [Published General Medicine eJournal - Sep 24 2014]
α1-antitrypsin modulates microglial-mediated n... [Published 7thSpace - Sep 23 2014]
Lost protein could prevent hardening of the art... [Published MyScience - Sep 22 2014]
MD Anderson announces encouraging results from ... [Published Individual.com - Sep 22 2014]
Blood Test Offers Specific Treatment for Ovaria... [Published Lab Medica - Sep 22 2014]
Recombinant vectors [Published PharmCast - Sep 21 2014]
Markers for determination of patient responsive... [Published PharmCast - Sep 21 2014]
In Vivo Evidence for Platelet-Induced Physiolog... [Published Plosone.org - Sep 20 2014]
Mesenchymal Stem Cells Augment the Anti-Bacteri... [Published Plosone.org - Sep 19 2014]
Patent Issued for Method for Inducing Tumor Apo... [Published 4 Traders - Sep 18 2014]
Patent Issued for Targeted Vectors for Cancer I... [Published HispanicBusiness.com - Sep 17 2014]
Leaders in Research & Scientific Sessions [Published MolecularImaging.net - Sep 16 2014]
Penticton family fights to recover cancer drug ... [Published Global News Canada - Sep 16 2014]
Feds give Cellerant $47.5M for stem cell treatm... [Published MedCity News - Sep 12 2014]
IL-10 and NOS2 Modulate Antigen-Specific Reacti... [Published Plosone.org - Sep 12 2014]
Researchers Submit Patent Application, "Antibod... [Published 4 Traders - Sep 11 2014]
Cellerant Awarded $47.5 Million Under Existing ... [Published Industrial Info Financials - Sep 11 2014]
Spectrum Pharmaceuticals to Advance Neutropenia... [Published Zacks.com - Sep 10 2014]
G1 Therapeutics Initiates Phase 1 Clinical Tria... [Published Benzinga.com - Sep 10 2014]
FortuneRock (China) Gets Investments Totaling $... [Published Pharmacy Choice - Sep 10 2014]
Sector Update: Health-Care Shares Mixed Pre-Market [Published Nasdaq - Sep 09 2014]
Spectrum Pharmaceuticals Makes Decision to Adva... [Published Finwin - Sep 09 2014]
Seven recent developments in atopic dermatitis ... [Published Orthopedics Today - Sep 05 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
FortuneRock (China) snags $24 mln [Published PE Hub Blog - Aug 26 2014]
FortuneRock (China) has raised $24 million in funding. The investors included Jinhua Pharmaceutical Co. Ltd . Based in Beijing, FortuneRock (China) is a biotech and biopharmaceutical firm. PRESS RELEASE BEIJING, Aug 25, 2014 (BUSINESS WIRE) — FortuneRock ...
Please help do i have parathyroidism? [Published HealthBoards - Aug 20 2014]
Hey guys! I am a 26 year-old male and I am trying to find out what is going on! This is all new to me because till now I have hardly ever been sick my whole life. I maybe had like 2 colds and that's it.Anyways so my symptoms started about 6-8 months or ...
Spectrum Pharma completes enrollment in Phase I... [Published PBR - News - May 30 2014]
Spectrum Pharmaceuticals has announced that the key Phase II trial of its long-acting granulocyte stimulating factor analog developed using LAPSCOVERY technology (SPI-2012) has completed its Phase II study enrollment; this positions Spectrum for Phase ...
Spectrum Pharmaceuticals Completes Enrollment i... [Published Business Wire Health News - May 28 2014]
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations and with a primary focus in Hematology and Oncology, today announced that the key phase ...
Study Confirms Mitochondrial Deficits In Childr... [Published Scientific Blogging - May 11 2014]
(SACRAMENTO, Calif.) — Children with autism experience deficits in a type of immune cell that protects the body from infection. Called granulocytes, the cells exhibit one-third the capacity to fight infection and protect the body from invasion compared ...
1 2

Press Releases

sort by: Date | Relevance
Galena Biopharma Completes Enrollment in GALE-3... [Published GlobeNewswire: Conference Call News - Jun 17 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.